Introduction: A 52-year-old man presented with extensive bilateral inflammatory myositis of the quadriceps on a background of pyrexia of unknown origin (PUO). He had markedly elevated acute phase reactants but had a normal CK and did not develop muscle weakness. This was a transient phenomenon which resolved spontaneously over 10 weeks. There was not an infective process identified and he was not treated with glucocorticoids or other immunosuppressants. This case highlights the importance of careful consideration of steroid treatment in atypical presentations without a clear diagnosis and the value of multidisciplinary involvement in patient care. Case description: The patient presented with a 2-week history of acute onset bilateral thigh pain, stiffness and persistent fevers following an episode of alcohol intake although symptoms may have preceded this. Myalgia was a prominent feature however he maintained full power of the hip flexors and all other proximal and distal muscle groups. No skin changes, swallow orrespiratory symptoms. CK was normal at presentation and remained low. Acute phase reactants were elevated including CRP 405mg/L, ESR 110mm/hr. Platelets 1000x10 9 /L, WCC 17.7x10 9 /L. Urinalysis and renal function normal. ALT raised at 136U/L. AST normal, other liver parameters raised in keeping with acute phase response. No previous episodes, no preceding travel, infection, bites, illicit drugs or family history of muscle disorders. He was taking astatin which was discontinued. PUO work up including cultures, viral titres, echocardiogram and CT imaging did not identify a source. Empiric antibiotics were trialled without improvement. ANA, ANCA and myositis panels were negative. MRI of thighs reported extensive inflammatory myositis involving the quadriceps bilaterally with mild involvement of biceps femoris. There were no features of an infected collection or rhabdomyolysis. Muscle biopsy showed a lymphocytic myositis with neurogenic atrophy. Differential included idiopathic inflammatory myositis (IIM) spectrum with viral myositis felt less likely. Clinically he remained sore but improving and mobilising. Daily pyrexias persisted but he remained fully strong with a low normal CK and a downward trend in inflammatory markers. Investigations for occult malignancy including CTPET and bone marrow biopsy were negative. Steroid treatment was not instigated. A watchful waiting approach was taken and his symptoms and blood investigations gradually improved. He embarked on a physiotherapist guided exercise programme. Follow up MRI at 10 weeks showed complete resolution of the inflammatory features. Discussion: This is a case of an acute onset myositis with systemic inflammatory features which resolved spontaneously. Differential diagnoses including inherited, metabolic and toxic myopathies were considered and discounted. Although alcohol had been taken and he had been taking a statin prior to onset, the clinical picture, normal CK and biopsy findings did not support these as likely culprits. Extensive viral and serology infective tests were negativeand the exact cause was not identified. The clinical features strongly mimicked an idiopathic inflammatory myositis (IIM) however atypical features including normal CK and lack of objective weakness led to continued doubt of an autoimmune aetiology. Additionally there were no upper limb or neck flexor symptoms and no extra-muscular manifestations. Applying the ACR/EULAR 2017 criteria for IIM to this case the probability of this diagnosis is 5% although this does not take into account the radiological findings. With evidence of inflammatory myositis and a dramatic acute phase response including persistent pyrexia there was a strong temptation to begin steroid therapy. His case was discussed with radiology, pathology and neurology and ultimately the decision towithholdwas justified. In this case improvement would have occurred with steroid which would likely have led to an incorrect diagnosis of IIM and the patient would have been unnecessarily treated with prolonged high dose steroid and disease modifying drugs with the associated side effects and long term sequelae. Key learning points: This case highlights the importance of confirming a diagnosis prior to initiating steroid therapy particularly if there are atypical features. Glucocorticoids would undoubtedly have led to a clinical improvement however this would have given rise to a misdiagnosis and unnecessary long term immunosuppression. There were many positive test results for inflammation including blood, imaging and muscle tissue but ultimately the clinical examination findings, particularly the absence of weakness, were consistent and the basis of the rationale to withhold steroid treatment. As clinical improvement progressed with supportive management this decision was justified. This demonstrates the importance of patient centred care and the value of the clinical examination. This was an unusual case therefore input and advice was sought from colleagues in neurology, neuropathology, rheumatology and radiology. This was vital to clinical care decisions and emphasizes the importance of a multidisciplinary approach in complex cases. Despite extensive investigations no cause was identified for this transient inflammatory myositis. This highlights the unknown elements within this spectrum of disease and the need forongoing reporting of atypical cases. Introduction: Myositis can be infective, metabolic or immune-mediated. Idiopathic inflammatory myopathy, which is immune-mediated, tends to be subacute, with symmetrical symptoms, overlap clinical features and positive autoimmune serology. We present a case of acute onset lower limb seronegative inflammatory myopathy with a normal creatinine kinase (CK), a marked acute phase response that responded promptly to immunomodulatory therapy. Case description: A 68-year-old man presented with a 2-week history of lower limb pain with subjective weakness, on a background of well-controlled type 2 diabetes mellitus and hypertension. He was admitted with worsening symptoms of markedleft thigh pain, night sweats, and fevers. On admission, he had swinging pyrexia (above >39 C) while remaining haemodynamically stable. He had focal tenderness over the left anterolateral thigh, with a good range of movement, normal power and no signs of focal collection or cellulitis. There were no extra-muscular features to suggest systemic infection oroverlap connective tissue disease. Bloods showed C-reactive protein (CRP) 225, normal CK 212 and negative blood cultures. X-rays knee, femur and pelvis were normal. Magnetic resonanceimaging (MRI)onT2,fat-suppressedSTIRsequencesdemonstrated increased signal/oedema both thighs throughout the anterior muscle compartment and along the fascial plane, notably most severe in the left vastus lateralis. He was treated empirically for infective myositis. Despite 14 days of broad-spectrum antibiotics, he remained febrile with persistently elevated CRP. There was no focal collection, lymphadenopathy or occult malignancy on CT abdomen and pelvis. Trans-oesophageal echocardiogram showed no evidence of infective endocarditis but revealed incidentalmoderate aortic stenosis.
The patient described persistent now bilateral thigh pain with continued normal CK and high CRP. Full autoimmune screen (ANA, ANCA, ACE and complement studies) was negative. Despite negative nuclear and cytoplasmic HEp-2 immunofluorence, extended myositis immunoblot was negative. Muscle biopsy from the left vastus lateralis demonstrated inflammation within the perimysium and perivasculature. In view of biopsy findings and no response to anti-microbial therapy, prednisolone (0.5mg/kg) with significant clinical response (resolution of fever and pain) with concurrent normalisation in CRP. The patient remains in remission following steroidreductionwithnoadditionalimmunomodulatorytherapyrequired. Discussion: We report a case of idiopathic inflammatory myopathy presenting with predominantly asymmetrical symptoms, normal CK, marked inflammatory response and negative myositis autoantibodies. Diagnosis was confirmed on MRI and muscle biopsy. The normal CK can beexplainedbythe histology demonstratinginflammation inperivascular regions and around muscle fibres, rather than inflammation or necrosis in the muscle fascicles and fibres themselves. Idiopathic inflammatory myopathy including sporadic inclusion-body myositis, dermatomyositis, overlap CTD myositis and polymyositis/necrotising myopathy subsets are distinguishable based on clinical features, autoantibodies, MRI and biopsy features. The table below summarises the atypical aspects of this case. Differential diagnoses for this case include atypical infection, sarcoid myopathy and amyloid myonecrosis secondary todiabetes. We report an interesting case of anti-PL-12/anti-SSA 52kD ASS presenting as acute digital ischemia, an association rarely described previously.
In cases with ILD, the severity of lung condition generally determines the prognosis.
Case description: A 77-year-old Caucasian female presented with sudden onset of painful, blue discolouration in her bilateral fingertips twoweeks after mild lower respiratory tract infection and occasional pyrexia. She was a non-smoker, otherwise independent lady who had background history of ischemic heart disease, diverticulosis and hypertension. Her physical examination revealed dusky blue digits and dry ulceration. She had extensive investigations that showed raised CRP (61mg/L), eGFR 39ml/min/1.73m2 , weak positive rheumatoid factor and cold agglutinins, equivocal Lupus anticoagulant, negative ANCA, clear urinalysis, bilateral chronic inflammatory change on chest xray and thrombi of digital arteries onDopplerultrasoundof hands. She was initially treated for infection due to ongoing temperatures and had multiple scans with no definite source. An inflammatory aetiology was then thought likely due to lack of response to antibiotics and steroid therapy was commenced with settling of fevers and inflammatory markers. Autoimmune screens initially were negative but became more prominent over time with a positive Ro antibody and ultimately a positive Anti PL12 antibody, keeping withanti-synthetase syndrome. She subsequently developed florid interstitial lung disease, further ischemia and ultimately necrosis of her fingertips. Due to the onset of lung disease she was treated with IV steroids, Cyclophosphamide and Prostaglandins with some initial benefit. She received 3 cycles of cyclophosphamide and managed to come off supplemental oxygen. However, she had issues with recurrent chest infections due to immunosuppressive therapy which resulted in delays in her cyclophosphamide pulses and need for antibiotics. She later developed clostridium-difficile gastroenteritis and subsequent ileus of her bowel which was managed conservatively and found it difficult to overcome. As time went on, the progress that she had made with her hands started to deteriorate again. There were also further issues with intestinal obstruction, and sadly ultimately passed away with aspiration pneumonia. Discussion: ASS is recognized as a rare autoimmune inflammatory myopathy of unknown etiology, 2-3 times more prevalent in women than in men. The clinical manifestations include myositis, polyarthritis, ILD, mechanic's hands, and Raynaud phenomenon. The hallmark of ASS is the presence of serum autoantibodies directed against aminoacyl-tRNA synthetases that include Jo-1, PL-7, PL-12, OJ, EJ, KS, Wa, YRS and Zo. Anti-jo1 is the most commonly detected antibody. These autoantibodies may arise after viral infections, or patients may have a genetic predisposition.
Our case was interesting as the autoimmune profile was positive for Anti-Ro/SSA and anti-PL-12. Anti-Ro/SSA and anti-La/SSB are traditionally associated with Sjö gren's disease and Sjö gren's-related ILD, however, anti-Ro/SSA has been independently associated with ASS and more severe and fibrotic ILD. It has been described that patients with anti-PL-12-ASS are most often clinically diagnosed with amyopathic dermatomyositis or ILD alone and there is higher prevalence and increased severity of ILD than PM/DM. Moreover, the prevalence of muscle symptoms (weakness and myalgia) is significantly lower in patients with anti-PL7/PL12 as compared to those with anti-Jo1 and less associated with malignancy as compared to DM. Interestingly, anti-PL-12 is also associated withhigher rates of Raynaudphenomenon.
Our case also reports that not all patients with antisynthetase antibodies or even those classified as ASS have all manifestations of this syndrome. Diagnostic criteria refers to presence of antisynthetase antibody plus two major criteria or one major criterion and two minor criteria (Solomon et all. 2011) or one or more of clinical features (Connors et all.2010). When the lungs are affected, the severity and extent of lung damage generally determines the prognosis because respiratory failure is the leading cause of death. Clinical presentation guides towards therapeutic management that mostly includes corticosteroids, immunosuppressive medications, and/or physical therapy Key learning points: Digital ischemia could be a rare presentation of ASS. Clinical features of antisynthetase syndrome (ASS) include interstitial lung disease, 'mechanic' hands, myositis, polyarthritis and Raynaud's phenomenon. Extensive myositis specific antibody testing is strongly recommended even if screening autoimmune serologies are unrevealing. Anti-PL-12 ASS has significantly lower prevalence of muscle symptoms (weakness and myalgia) and more association with Raynaud'sphenomenon ascomparedto thosewith anti-Jo1.It is imperative to recognize lesser-known manifestations of ASS in the absence of clinical myositis as delay in diagnosis and treatment worsens the prognosis.
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